| Name | Title | Contact Details |
|---|---|---|
Vinay Gidwaney |
Head of Technology | Profile |
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Since 1994, PEPID has been a leading developer of clinical and drug information resources and mobile apps for healthcare providers, hospitals and schools. PEPIDs collection of clinical decision support resources help healthcare professionals become better clinicians and, most importantly, improves patient outcomes by aiding in diagnosis and management.
Fenner Physician Svc Corp is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Field Safety Corp is a Guilford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IN Compass Health is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.